HIGHLIGHTS
- who: Regis Goulart Rosa et al. from the Collegeville, PA, United States of America, Research Institute, HMV, Porto Alegre, RS, Brazil, Unimed, Porto Alegre, RS, Brazil, Otus Solutions, Porto Alegre, RS, Brazil, Universidade Federal do Paranau0301 have published the paper: BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan, in the Journal: PLOS ONE of June/11,/2021
- what: Funding: This study has been conducted as a collaboration between Hospital Moinhos de Vento and Pfizer. The study is being conducted among patients aged 12 years or older . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.